Concepedia

Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial

Shihui Chen, Xiaolan Zhao, Li Ran, Jing Wan, Xiaofang Wang, Yu Qin, Furong Shu, Yanxiang Gao, Lijia Yuan, Qianyong Zhang,

Digestive and Liver Disease · 2014 · 312 citations · 35 references

DOI

Concepts

References

35

Dose translation from animal to human studies revisited

Shannon Reagan‐Shaw, Minakshi Nihal, Nihal Ahmad · The FASEB Journal · 2007 · 6.3K citations

, , +13

Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆

Christi A Matteoni, Zobair M. Younossi, T GRAMLICH et al. · Gastroenterology · 1999 · 3.4K citations · Full text

, , +14

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

Silvie Timmers, Ellen Konings, Lena Bilet et al. · Cell Metabolism · 2011 · 1.3K citations · Full text

, , +17

Identification of a novel FGF, FGF-21, preferentially expressed in the liver

Tetsuya Nishimura, Yuhki Nakatake, Morichika Konishi et al. · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · 2000 · 838 citations

, , +11

Cytokeratin-18 Fragment Levels as Noninvasive Biomarkers for Nonalcoholic Steatohepatitis

Ariel E. Feldstein, Anna Więckowska, Rocío López et al. · Hepatology · 2009 · 698 citations · Full text

, , +17